Alcon Reports Q1 2026 Earnings with 6% Revenue Growth
Alcon (ALC) reported Q1 2026 earnings with total sales of $2.7 billion, reflecting 6% constant-currency growth driven by new product contributions and price increases. Surgical and vision care revenue both rose by 6%, though surgical revenue faced challenges from international pressures and supply issues. Core gross margin dipped slightly due to tariff headwinds.
Topics: cash_flow earnings margin revenue sales share_repurchase tariffs